- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03416946
Custom Cutting Block Instrument vs Regular Instrumentation Total Knee Replacement (TKR)
September 30, 2021 updated by: Dr. Thomas Turgeon, Orthopaedic Innovation Centre
A Double-blinded, Randomized, Controlled Trial of Total Knee Replacement Using Custom Cutting Block Instrument vs Regular Instrumentation
To determine if the use of patient-specific custom cutting blocks for implantation of total knee components results in improved limb alignment and component positioning compared to regular instrumentation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial.
Patients will be randomized to have their knee implanted using either the patient-specific custom cutting blocks or the regular instrumentation system.
Functional and radiographic outcomes will be assessed in a blinded fashion.
The Smith and Nephew Legion Primary® total knee system will be used in both groups; this is an implant with a good long term track record based on the Genesis II design.
All surgeons have used and are familiar with the regular instrumentation.
They will be instructed in the use of the patient-specific custom cutting blocks prior to study initiation.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2K 3S8
- Concordia Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient is male or female ages 18 and over.
- Patient is having primary total knee replacement
- Patient is willing to sign the informed consent and to come for all study visits.
Exclusion Criteria:
- Deformity of the femur preventing use of the intra-medullary guide utilized in the regular instrumentation set.
- Necessity for the use of constrained implants. These types of implants have intra-medullary stems, therefore all bone cuts need to be referenced off intramedullary guides, making image guided bone cuts inappropriate.
- Patients undergoing knee replacement revision surgery. Theses types of implants also have stems, making the use of image guided bone cuts inappropriate for the same reasons.
- Patients scheduled for bilateral knee surgery (simultaneous or staged)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Custom Block Instrumentation
Patients-specific custom cutting blocks using the Smith and Nephew Visionaire system
|
Custom cutting block using MRI to create patient specific instrumentations
|
|
Active Comparator: Traditional Instrumentation
Traditional cutting methods for Total Knee Replacement
|
Traditional cutting method
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic Alignment
Time Frame: 8 Weeks
|
Using 3 foot standing film
|
8 Weeks
|
|
Number of HKA Angle Outliers
Time Frame: 8 Weeks
|
The angle formed between the mechanical axes of the femur and tibia create the hip-knee-ankle (HKA) angle.
|
8 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EuroQol (EQ) Five Dimension (5D) Survey
Time Frame: Preoperative, 1 and 2 years
|
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the EQ-5D (patient reported).
The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state, this health state is range from 0 to 1.0.
Higher scores indicate improved quality of life within each dimension.
|
Preoperative, 1 and 2 years
|
|
Oxford Knee Score
Time Frame: Preoperative, 1 and 2 years
|
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the Oxford 12 scores (patient reported).
The score ranges from 0 to 48 with higher scores indicating improved function and less pain.
|
Preoperative, 1 and 2 years
|
|
Pain Catastrophizing Scale (PCS) Score
Time Frame: Preoperative, 1 and 2 years
|
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the PCS (patient reported).
The total score ranges from 0 to 52 with higher scores indicating greater pain catastrophizing.
Sub-scales will not be used in this study.
|
Preoperative, 1 and 2 years
|
|
Hip Pain
Time Frame: Preoperative, 1 and 2 years
|
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the Pain Visual Analog Scale (VAS).
The scale is from 0 to 100, 0=no pain and at 100= worst pain.
(patient reported).
|
Preoperative, 1 and 2 years
|
|
University of California Los Angeles (UCLA) Activity Score
Time Frame: Preoperative, 1 and 2 years
|
Evaluate change from preoperative baseline to 1 and 2 year post operative in activity level assessments using the UCLA Activity score (patient reported).
The scale ranges from 1-10 with higher values associated with more intense activities.
|
Preoperative, 1 and 2 years
|
|
Patient Satisfaction
Time Frame: Preoperative, 1 and 2 years
|
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the Satisfaction Visual Analog Scale (VAS).
The scale is from 0 to 100, 0=Not Satisfied and at 100=Satisfied.
(patient reported).
|
Preoperative, 1 and 2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other Measure: Time
Time Frame: Intra-operative
|
Surgical and tourniquet time
|
Intra-operative
|
|
Blood Loss
Time Frame: Intra-operative
|
Blood loss during surgery >100ml (n)
|
Intra-operative
|
|
Length of Stay (LOS)
Time Frame: Peri-operative
|
Length of hospital stay
|
Peri-operative
|
|
Other Measures: Adverse Events
Time Frame: Peri-operative, intra-operative and post-operative
|
Peri-operative complications such as deep venous thrombosis, pulmonary emboli, wound complications and cardiac events. Post-operative complication such as infection, loosening, etc. |
Peri-operative, intra-operative and post-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas Turgeon, MD MPH FRCSC, Orthopaedic Innovation Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2011
Primary Completion (Actual)
May 1, 2017
Study Completion (Actual)
May 1, 2017
Study Registration Dates
First Submitted
December 13, 2017
First Submitted That Met QC Criteria
January 24, 2018
First Posted (Actual)
January 31, 2018
Study Record Updates
Last Update Posted (Actual)
October 4, 2021
Last Update Submitted That Met QC Criteria
September 30, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS13322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingKnee Osteoarthritis | Knee Osteoarthritis in VarusRussia
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Visionaire
-
Smith & Nephew Orthopaedics AGTerminatedOsteoarthritis of the KneeUnited Kingdom
-
Lawson Health Research InstituteSmith & Nephew, Inc.; Canadian Orthopaedic FoundationCompleted
-
Smith & Nephew, Inc.CompletedOsteoarthritis, KneeSouth Africa
-
Smith & Nephew, Inc.TerminatedDegenerative Arthritis of KneeUnited States, Australia